Expert Comments on Minnesota’s Psilocybin Therapeutic Use Program HF2906 (2025)
Minnesota legislators introduced HF2906 to establish a psilocybin therapeutic use program for adults with qualifying medical conditions. D4DPR submitted expert testimony offering clinical perspective to inform the committee's review.
.svg)